Main menu button

Nyheter

Equity research Immunovia: First impression, Q3 2025 - Successful rights issue to fuel launch and reimbursement progress
26 nov 2025
Equity research Immunovia: First impression, Q3 2025 - Successful rights issue to fuel launch and reimbursement progress
Analysmaterial Immunovia
Carlsquare advised KKA Partners and its portfolio company Mühldorfer Nutrition Holding on the acquisition of a majority stake in Dr. Clauder Group of Companies
24 nov 2025
Carlsquare advised KKA Partners and its portfolio company Mühldorfer Nutrition Holding on the acquisition of a majority stake in Dr. Clauder Group of Companies
Deal News
Analys Zinzino kv3 2025: En magkänsla för tillväxt
24 nov 2025
Analys Zinzino kv3 2025: En magkänsla för tillväxt
Analysmaterial Zinzino
Equity research Viva Wine Group, Q3 2025: Strong Nordics support margin targets
21 nov 2025
Equity research Viva Wine Group, Q3 2025: Strong Nordics support margin targets
Analysmaterial Viva Wine Group
Carlsquare advised the founder of EKB GmbH on the sale to the Westbridge-Group, a portfolio company of Permira
20 nov 2025
Carlsquare advised the founder of EKB GmbH on the sale to the Westbridge-Group, a portfolio company of Permira
Deal News
Equity research Viva Wine Group: First impression, Q3 2025 - Better than expected in soft market
20 nov 2025
Equity research Viva Wine Group: First impression, Q3 2025 - Better than expected in soft market
Analysmaterial Viva Wine Group
Carlsquare exclusively advised DBAG Fund VIII on the acquisition financing of MAIT
19 nov 2025
Carlsquare exclusively advised DBAG Fund VIII on the acquisition financing of MAIT
Deal News
Analys Zinzino: Första intrycket, kv3 2025 - Positiv marginalöverraskning
19 nov 2025
Analys Zinzino: Första intrycket, kv3 2025 - Positiv marginalöverraskning
Analysmaterial Zinzino
HealthTech M&A 2025: Efficiency, consolidation & AI as growth catalysts
18 nov 2025
HealthTech M&A 2025: Efficiency, consolidation & AI as growth catalysts
Insights
Human Capital Management 2025: Navigating Growth, AI & Regulation
18 nov 2025
Human Capital Management 2025: Navigating Growth, AI & Regulation
Insights
Analys Angler Gaming, kv3 2025: Ett kvartal över förväntan
14 nov 2025
Analys Angler Gaming, kv3 2025: Ett kvartal över förväntan
Analysmaterial Angler Gaming
Analys Elicera Therapeutics, kv3 2025: CARMA-studien fortskrider, avrapportering om ELC-100 inom kort
14 nov 2025
Analys Elicera Therapeutics, kv3 2025: CARMA-studien fortskrider, avrapportering om ELC-100 inom kort
Analysmaterial Elicera Therapeutics
European Debt Markets Q3 2025 – Carlsquare Insights
12 nov 2025
European Debt Markets Q3 2025 – Carlsquare Insights
Insights
Analys Angler Gaming, kv3 2025: Både omsättning och lönsamhet över förväntan
12 nov 2025
Analys Angler Gaming, kv3 2025: Både omsättning och lönsamhet över förväntan
Analysmaterial Angler Gaming
Analys Odinwell: Videointervju med VD Marcus Andersson
11 nov 2025
Analys Odinwell: Videointervju med VD Marcus Andersson
Analysmaterial Odinwell
Analys Nodebis, kv3 2025: Fortsatt fin utveckling i kv3
11 nov 2025
Analys Nodebis, kv3 2025: Fortsatt fin utveckling i kv3
Analysmaterial Nodebis
Equity research White Pearl Technology Group, Q3 2025: Strong momentum supports aspirational targets
07 nov 2025
Equity research White Pearl Technology Group, Q3 2025: Strong momentum supports aspirational targets
Analysmaterial White Pearl Technology Group
Carlsquare advised the shareholders of CONTRACTOR Group on the sale to 7N Group
06 nov 2025
Carlsquare advised the shareholders of CONTRACTOR Group on the sale to 7N Group
Deal News
Analys Enrad, kv3 2025: Ett starkt kvartal över förväntan
06 nov 2025
Analys Enrad, kv3 2025: Ett starkt kvartal över förväntan
Analysmaterial Enrad
Equity research White Pearl Technology Group: First impression, Q3 2025 - Strong EBITDA margin
05 nov 2025
Equity research White Pearl Technology Group: First impression, Q3 2025 - Strong EBITDA margin
Analysmaterial White Pearl Technology Group